[go: up one dir, main page]

MXPA03000207A - Formulacion liposomica de propionato de clobetasol. - Google Patents

Formulacion liposomica de propionato de clobetasol.

Info

Publication number
MXPA03000207A
MXPA03000207A MXPA03000207A MXPA03000207A MXPA03000207A MX PA03000207 A MXPA03000207 A MX PA03000207A MX PA03000207 A MXPA03000207 A MX PA03000207A MX PA03000207 A MXPA03000207 A MX PA03000207A MX PA03000207 A MXPA03000207 A MX PA03000207A
Authority
MX
Mexico
Prior art keywords
clobetasol propionate
formulation
active substance
liposomes
liposomic
Prior art date
Application number
MXPA03000207A
Other languages
English (en)
Inventor
Cortada Dinorah Granda
Original Assignee
Ct De Investigacion Y Desarrol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Investigacion Y Desarrol filed Critical Ct De Investigacion Y Desarrol
Publication of MXPA03000207A publication Critical patent/MXPA03000207A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se relaciona con una formulacion liposomica de propionato de clobetasol para uso topico para el tratamiento de enfermedades de la piel como dermatitis atopica y psoriasis con excelente aspecto organoleptico, muy buen efecto terapeutico y favorable distribucion en el estrato corneo. Los liposomas incluyen el propionato de clobetasol como principio activo en bajas dosis. Estos liposomas son preferiblemente vesiculas estables y multilamelares con un tamano medio entre 2000 - 5000 nm. La cantidad de principio activo es preferiblemente entre 0.02 y 0.025 %. La forma farmaceutica del producto es preferiblemente jalea.
MXPA03000207A 2000-07-17 2001-07-17 Formulacion liposomica de propionato de clobetasol. MXPA03000207A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20000171A CU23175A1 (es) 2000-07-17 2000-07-17 Formulacion liposomica de propionato de clobetasol
PCT/CU2001/000005 WO2002007702A2 (es) 2000-07-17 2001-07-17 Formulación liposómica de propionato de clobetasol

Publications (1)

Publication Number Publication Date
MXPA03000207A true MXPA03000207A (es) 2004-09-13

Family

ID=40134847

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000207A MXPA03000207A (es) 2000-07-17 2001-07-17 Formulacion liposomica de propionato de clobetasol.

Country Status (12)

Country Link
EP (1) EP1360958B1 (es)
CN (1) CN100346773C (es)
AT (1) ATE339188T1 (es)
AU (2) AU7625401A (es)
BR (1) BR0112553A (es)
CA (1) CA2416731C (es)
CU (1) CU23175A1 (es)
DE (1) DE60123132T2 (es)
DK (1) DK1360958T3 (es)
ES (1) ES2272508T3 (es)
MX (1) MXPA03000207A (es)
WO (1) WO2002007702A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291626B1 (en) 1998-04-09 2007-11-06 John Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
IL149069A0 (en) 1999-10-13 2002-11-10 Univ Johns Hopkins Med Regulators of the hedgehog pathway, compositions and uses related thereto
CA2452152A1 (en) 2001-07-02 2002-10-10 Sinan Tas Use of cyclopamine in the treatment of psoriasis
DE60113733T2 (de) * 2001-07-02 2006-06-29 Tas, Sinan Verwendung von cyclopamine, zur behandlung des basalzellkarzinoms und anderer tumoren
US20180235882A1 (en) 2015-09-02 2018-08-23 Cadila Healthcare Limited Topical compositions comprising corticosteroids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
AU661754B2 (en) * 1992-02-12 1995-08-03 Janssen - Cilag - S.p.a. Liposomal itraconazole formulations

Also Published As

Publication number Publication date
WO2002007702A3 (es) 2003-07-31
AU7625401A (en) 2002-02-05
HK1071070A1 (zh) 2005-07-08
DE60123132T2 (de) 2007-04-12
ATE339188T1 (de) 2006-10-15
CU23175A1 (es) 2006-09-22
CA2416731C (en) 2009-12-15
CN1547465A (zh) 2004-11-17
EP1360958A2 (en) 2003-11-12
WO2002007702A2 (es) 2002-01-31
EP1360958B1 (en) 2006-09-13
CA2416731A1 (en) 2003-01-16
BR0112553A (pt) 2003-06-24
DE60123132D1 (de) 2006-10-26
ES2272508T3 (es) 2007-05-01
CN100346773C (zh) 2007-11-07
DK1360958T3 (da) 2007-01-29
AU2001276254B2 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
US20240115707A1 (en) Dna repair composition
EP0215108B1 (en) Compositions for treating acne vulgaris and methods of making same
WO2002015860A1 (en) Topical antioxidant having vitamin c and method of combination with topical agent by user
KR20050105461A (ko) α,α-트레할로오스의 당질 유도체를 함유하는 것을 특징으로 하는 피부 외용제
US20100129465A1 (en) Methods and Compositions Related to Acne Treatment
TW201321022A (zh) 供皮膚回春之組合物及方法
US20110236503A1 (en) Topical Skincare Composition
CA2280253A1 (en) Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
US20060088497A1 (en) Topical skin care composition
KR20060019540A (ko) 경피 투여용 국소 조성물
CN105853300A (zh) 一种去油去屑止痒滋润型洗头膏及其制备方法
MXPA03000207A (es) Formulacion liposomica de propionato de clobetasol.
KR102393943B1 (ko) 피부 및 두피 케어용 바이오필름 제거 조성물
US20060150988A1 (en) Method of transdermal and transmucosal absorption of carbon dioxide and cosmetic method and therapeutic method
KR100206721B1 (ko) 화장용 방취 및 항균 조성물
KR20220006324A (ko) 스피큘을 포함하는 화장품 조성물 및 그 제조방법
CN114452257B (zh) 一种用于皮肤护理的二硫化硒泡沫剂及其制备方法
CN104940046B (zh) 一种医用生物紧肤敷料及其制备方法
US20240082136A1 (en) Topical composition
TWM656940U (zh) 植物源生物活性肽的脂質體包覆結構
JPS62142119A (ja) アトピ−性皮膚炎治療用クリ−ム組成物
Millward Skincare Benefits of Phosphatidylcholine
Lee et al. New Developments in Topical Psoriasis Therapy
PIOLATTO Hair and Skin Health
JPS62195330A (ja) 皮膚外用剤

Legal Events

Date Code Title Description
FG Grant or registration